Mirae Asset Global Etfs Holdings Ltd. Ironwood Pharmaceuticals Inc Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $56.2 Billion
- Q3 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 72,971 shares of IRWD stock, worth $229,128. This represents 0.0% of its overall portfolio holdings.
Number of Shares
72,971
Previous 87,435
16.54%
Holding current value
$229,128
Previous $62,000
53.23%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding IRWD
# of Institutions
186Shares Held
160MCall Options Held
11.2MPut Options Held
11.7K-
Black Rock Inc. New York, NY22.9MShares$71.8 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY16.2MShares$50.7 Million0.32% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.1MShares$50.5 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT15.9MShares$50 Million13.13% of portfolio
-
Bank Of America Corp Charlotte, NC11.7MShares$36.7 Million0.0% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $481M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...